Your browser doesn't support javascript.
loading
Pancreatic cancer survival prediction via inflammatory serum markers.
Lanki, Mira; Seppänen, Hanna; Mustonen, Harri; Salmiheimo, Aino; Stenman, Ulf-Håkan; Salmi, Marko; Jalkanen, Sirpa; Haglund, Caj.
Afiliação
  • Lanki M; Department of Surgery, University of Helsinki and Helsinki University Hospital, PO BOX 22, 00014, Helsinki, Finland. mira.lanki@helsinki.fi.
  • Seppänen H; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. mira.lanki@helsinki.fi.
  • Mustonen H; Department of Surgery, University of Helsinki and Helsinki University Hospital, PO BOX 22, 00014, Helsinki, Finland.
  • Salmiheimo A; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Stenman UH; Department of Surgery, University of Helsinki and Helsinki University Hospital, PO BOX 22, 00014, Helsinki, Finland.
  • Salmi M; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Jalkanen S; Department of Surgery, University of Helsinki and Helsinki University Hospital, PO BOX 22, 00014, Helsinki, Finland.
  • Haglund C; Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Cancer Immunol Immunother ; 71(9): 2287-2292, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35034144

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article